NCT05509647View on ClinicalTrials.gov

Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Heparin Overdose of Undetermined IntentCOVID-19
Interventions
DRUG

Unfractionated heparin

Patients are treated with unfractionated heparin aiming at aPTT 60-80 sec and/or anti-Xa levels of 0.3-0.7 iE/ml

Trial Locations (1)

2333ZA

Leiden University Medical Centre, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT05509647 - Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients | Biotech Hunter | Biotech Hunter